Acquisition Context BD potential given recent news that Becton Dickinson and Company plans to acquire Owen Mumford Ltd. This creates a near-term runway for partner discussions around transition services, integration capabilities, and enhanced drug delivery platform collaborations to retain market position and accelerate scale.

Safety Platform EcoSafe safety syringe platform launch in UK demonstrates a focus on safer, reusable autoinjector options. Opportunity to upsell expanded safety and compliance features to global pharma, biotech, and generics partners seeking patient safety improvements and regulatory alignment.

Global Footprint Manufacturing in the UK and Malaysia with US, German, and French subsidiaries offers regional deployment and co-development opportunities. Targeted outreach to multi-region sponsors for platform products and fast-to-market programs can reduce complexity and regional regulatory risk.

Service Synergy Strong services portfolio including human factors, regulatory, final assembly and packaging complements device design. Use as a differentiator to offer end-to-end development and regulatory support to customers seeking quicker, compliant market entry.

Industry Engagement Active industry presence through conferences such as PDA Universe of Pre-Filled Syringes and Injection Devices and DCAT Week indicates opportunities for partner engagement, demonstrations of platform products, and pipeline development with key decision-makers.